Bacterial melanins have already been tested in number of animal models of neurodegeneration, including models of Parkinson’s disease [15], but the effect of melanin in Alzheimer’s disease (AD), as acetylcholinesterase (AChE) inhibitor, was not found in the bibliography. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.